Empagliflozin-Induced Changes in Epicardial Fat The Centerpiece for Myocardial Protection?

被引:21
|
作者
Mullens, Wilfried
Martens, Pieter
机构
[1] Ziekenhuis Oost Limburg, Genk, Belgium
[2] Univ Hasselt, Biomed Res Inst, Fac Med & Life Sci, Hasselt, Belgium
关键词
CMR; epicardial adipose tissue; heart failure; myocardial fibrosis; SGLT2-inhibitors;
D O I
10.1016/j.jchf.2021.05.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:590 / 593
页数:4
相关论文
共 50 条
  • [21] Epicardial fat: An unrecognized cause of artifact on myocardial perfusion imaging
    Akinboboye, Olakunle O.
    Nichols, Kenneth
    Dim, Uzodinma R.
    Wang, Yi
    Chhabra, Shalini
    Milo, Tom
    CLINICAL NUCLEAR MEDICINE, 2006, 31 (06) : 333 - 334
  • [22] Age and sex mediated changes in epicardial fat adipokines
    Fei, Jia
    Cook, Carla
    Blough, Eric
    Santanam, Nalini
    ATHEROSCLEROSIS, 2010, 212 (02) : 488 - 494
  • [23] Cardiometabolic protection by reduction of epicardial fat tissue. MicroRNA and adipokine-mediated interaction of epicardial fat tissue and myocardium
    Niemann, B.
    Li, L.
    Grieshaber, P.
    Dominik, E.
    Boening, A.
    Rohrbach, S.
    ZEITSCHRIFT FUR HERZ THORAX UND GEFASSCHIRURGIE, 2015, 29 (04): : 270 - 276
  • [24] Empagliflozin reduces the doxorubicine-induced myocardial dysfunction
    Sabatino, J.
    Yasuda, M.
    De Rosa, S.
    Tamme, L.
    Iaconetti, C.
    Albanese, M.
    Zaccone, G.
    Mignogna, C.
    Aquila, I.
    Donato, G.
    Indolfi, C.
    EUROPEAN HEART JOURNAL, 2017, 38 : 862 - 862
  • [25] Empagliflozin prevents doxorubicin-induced myocardial dysfunction
    Sabatino, Jolanda
    De Rosa, Salvatore
    Tamme, Laura
    Iaconetti, Claudio
    Sorrentino, Sabato
    Polimeni, Alberto
    Mignogna, Chiara
    Amorosi, Andrea
    Spaccarotella, Carmen
    Yasuda, Masakazu
    Indolfi, Ciro
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01) : 66
  • [26] Empagliflozin prevents doxorubicin-induced myocardial dysfunction
    Jolanda Sabatino
    Salvatore De Rosa
    Laura Tammè
    Claudio Iaconetti
    Sabato Sorrentino
    Alberto Polimeni
    Chiara Mignogna
    Andrea Amorosi
    Carmen Spaccarotella
    Masakazu Yasuda
    Ciro Indolfi
    Cardiovascular Diabetology, 19
  • [27] PROGNOSTIC IMPLICATION OF EPICARDIAL AND PERICARDIAL FAT ACUTELY AFTER MYOCARDIAL INFARCTION
    Hyodo, Eiichi
    Shimada, Kenei
    Saito, Toshio
    Fujiwara, Toshiki
    Tamita, Koichi
    Yamamuro, Atsushi
    Muro, Takashi
    Yoshiyama, Minoru
    Yoshikawa, Junichi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1010 - E1010
  • [28] Evaluation of epicardial and intra-myocardial fat in a patient with mitochondrial cardiomyopathy
    Okayama, Satoshi
    Uemura, Shiro
    Saito, Yoshihiko
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (02) : E43 - E45
  • [29] Does epicardial fat contribute to COVID-19 myocardial inflammation?
    Malavazos, Alexis Elias
    Goldberger, Jeffrey J.
    Iacobellis, Gianluca
    EUROPEAN HEART JOURNAL, 2020, 41 (24) : 2333 - 2333
  • [30] MYOCARDIAL CREATINE PHOSPHOKINASE ACTIVITY AND EPICARDIAL CHANGES FOLLOWING EXPERIMENTAL MYOCARDIAL INFRARCTION
    MAROKO, PR
    KJEKSHUS, JK
    SOBEL, BE
    BRAUNWAL.E
    FEDERATION PROCEEDINGS, 1970, 29 (02) : A518 - +